Please assess the completion status of the following clinical trial:

Trial Title: Staccato Loxapine in Agitated Patients With Bipolar Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female adult patients with bipolar 1 disorder and acute agitation~Exclusion Criteria:~* Agitation caused primarily by acute intoxication~* History of drug or alcohol dependence~* Treatment with benzodiazepines or other hypnotics within 4 hours prior to study drug administration

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Inhaled Placebo (Type: PLACEBO_COMPARATOR): Inhaled Staccato Placebo, may repeat after 2 hours x 2
- Inhaled Loxapine 5 mg (Type: EXPERIMENTAL): Inhaled Staccato Loxapine 5 mg, may repeat after 2 hours x 2
- Inhaled Loxapine 10 mg (Type: EXPERIMENTAL): Inhaled Staccato Loxapine 10 mg, may repeat after 2 hours x 2

Based on this trial design, predict the completion outcome and termination type (if applicable).